rhTPO in Critical Patients With Thrombocytopenia

Clinical trial NCT02094248 · UNKNOWN

Trial details

NCT number: NCT02094248
Sponsor: Jinling Hospital, China
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Sepsis Thrombocytopenia

Start date: 2014-03-01
Primary completion: 2016-03-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.